Skip to main content
Log in

Intra-arterial BCNU in the treatment of recurrent medulloblastoma

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Two patients with recurrent medulloblastomas were treated with combined oral and intra-venous chemotherapy followed by intra-arterial BCNU. The 7 days course of oral and intra-venous chemotherapy consisted of CCNU and Procarbazin orally and Vincristine intra-venously (PCV), repeated after 6 weeks. Intra-arterial chemotherapy consisted of 4 cycles of BCNU. Both patients responded well to treatment, evaluated by CT scans. One of the patients died of a new local recurrence 6 months after initiation of chemotherapy, whereas the other patient remains well, without CT evidence of tumour 36 months after the start of the treatment. No serious adverse side-effects related to the treatment were seen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baily P, Cushing H: Medulloblastoma cerebelli: A common type of midcerebellar glioma of childhood. Arch Psychiatry 1925; 14: 192–224

    Google Scholar 

  2. Bloom HJG, Wallace ENK, Henk JM: The treatment and prognosis of medulloblastoma in children: A study of 82 verified cases. Am J Roentgenol Rad Ther Nucl Med 1969; 105:43–62

    Google Scholar 

  3. Koos WT, Miller MT: Intracranial tumours of infant and children. Stuttgart: Georg Thime, 1971; 205–213

    Google Scholar 

  4. Matson DD: Neourosurgery of infancy and childhood, 2nd ed. Springfield, Illinois: Charles C Thomas, 1969; 448–456

    Google Scholar 

  5. Kapelson G MD, Linggood RM: Medulloblastoma in adults. Cancer 49: 1334–1337, 1982

    Google Scholar 

  6. Cutler, Sosman M, Vaughan W: The place of radiation in the treatment of cerbellar medulloblastoma: Am J Roentgenol. 35: 429–453, 1936

    Google Scholar 

  7. Lampe T, MacIntyre RS: Medulloblastoma of the cerebellum. Arch Neurol Psych 62: 322–329, 1919

    Google Scholar 

  8. Penfield W, Feindel J: Medulloblastomaofcerebellum with survival for seventeen years. Arch Neurol Psych 57: 481–484, 1947

    Google Scholar 

  9. Cushing H: Experiency with cerebellar medulloblastoma. Acta Pathol Microbiol Scand, 7: 1–86, 1930

    Google Scholar 

  10. Craigh L, Silverman MD, Simpson JR MD: Cerebellar medulloblastoma. Int J Radiation Oncol Biol Phys vol 8, 1869–1876, 1982

    Google Scholar 

  11. Harisiadis L, Change CH: Medulloblastoma in children: A correlation between staging and results of treatment. Int J Radiat Oncol Biol Psys 1977; 2: 833–841

    Google Scholar 

  12. Mealey J, Hall PV: Medullosblastoma in children: Survival and treatment. J Neurosurg 1977; 46: 56–64

    Google Scholar 

  13. Quest DO, Brisman R, Antunes JL, Houspian EM: Period of risk for recurrence in medulloblastoma. J Neurosurg 1978; 48: 159–163

    Google Scholar 

  14. Berry M, Jenken R: Radiation treatment for medulloblastoma. J Neurosurg 55: 43–51, 1981

    Google Scholar 

  15. Brown R, Gunderson L: Medulloblastoma. Cancer 40: 55–60, 1977

    Google Scholar 

  16. Smith CE, Long DM: Medulloblastoma. Cancer 32: 722–728, 1973

    Google Scholar 

  17. Silverman CL, Simpson JR: Cerebellar medulloblastoma: The importance of posterior fossa dose to survival and patterns of failure. Int J Radiat Oncol Biol Psys 1982; 8: 1869–1876

    Google Scholar 

  18. Edwards MB, Levin VA, Wilson CB: Brain tumour chemotherapy: an evaluation of agents in current use of Phase II–III studies. Cancer Treat Rep 1980, 64: 1179–205

    Google Scholar 

  19. Gutin PH, Philips TL, Wara W, et al: Brachytherapy of recurrent malignant brain tumours with removable high activity iodine-125 sources. J Neourosurg 1984; 60: 61–8

    Google Scholar 

  20. Christ W et al: Chemotherapy of childhood medulloblastomas. Cancer J Dis child, 30: 6–39, 1976

    Google Scholar 

  21. Jereb et al: Bertga Jereb: Supratentioral recurrences in medulloblastomas. Cancer 47, 806–809, 1981

    Google Scholar 

  22. Wannemachor et al: Fortschiffte in der therapie des Medulloblastomas. Onkologie 1: 92–96, 1978

    Google Scholar 

  23. Crafts DC, Levin VA, Edwards MS, Pischer TL, Wilson CB: Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, vincristine. J Neurosurg 1978; 49: 589–592

    Google Scholar 

  24. Levin VA, Vestnys PS, Edwards MS, Wara WM, Fulton D, Barger G, Seager M, Wilson CB: Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma. Cancer 1983; 51: 1364–1370

    Google Scholar 

  25. Walker RW, Allen JC, Bacha D, Tan C: Treatment of recurrent primary brain tumours of childhood with carboplatin. Ann Neurology 1985; 18: 406

    Google Scholar 

  26. Ward HWC: CCNU in treatment of recurrent medulloblastoma. Br Med J 1974; 1: 642

    Google Scholar 

  27. Collin JM: Pharmacologic Rationale for Reginal Drug Delivery. J Clin Oncol 1984; 2: 498–504

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watne, K., Hager, B. & Hirschberg, H. Intra-arterial BCNU in the treatment of recurrent medulloblastoma. J Neuro-Oncol 8, 139–143 (1990). https://doi.org/10.1007/BF00177836

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00177836

Key words

Navigation